Clinical Trial Update: Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the cardiac safety of dihydroartemisinin-piperaquine in pregnant women with malaria in Tanzania.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Pregnancy Malaria

Drugs mentioned

• Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria, Pregnancy Malaria | Phase 2 | Status: COMPLETED